| Pablo R Razo, MD | |
|
999 San Bernardino Rd, Upland, CA 91786-4920 | |
| (909) 985-2811 | |
| (818) 587-2493 |
| Full Name | Pablo R Razo |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Experience | 25 Years |
| Location | 999 San Bernardino Rd, Upland, California |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1700809233 | NPI | - | NPPES |
| 00A734870 | Other | CA | BLUE SHIELD |
| 00A734870 | Medicaid | CA | |
| P00199880 | Other | CA | RAILROAD MEDICARE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | A73487 (California) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| San Antonio Regional Hospital | Upland, CA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Mountain View Emergency Physicians Medical Group Inc | 5092606376 | 29 |
News Archive
Owlstone Medical, the global leader in Breath Biopsy® for applications in early disease detection and precision medicine, today announced the appointment of Mark Capone, former President and CEO of Myriad Genetics to its Board as an independent non-executive director.
Bruker Corporation today announced that it has acquired all of the shares of SkyScan N.V., a scientific instruments company located near Antwerp, Belgium. Financial details were not disclosed. For the remainder for 2012, the acquisition of SkyScan is expected to add approximately $13 million to Bruker's revenue and to be accretive to EPS by about $0.01.
Bayer's CONTOUR® USB meter, the first blood glucose monitor with unique plug & play diabetes management software, today received a silver Medical Design Excellence Award (MDEA). The MDEA recognizes excellence in medical product design and manufacturing. The independent judges for the prestigious award, sponsored by the specialist journal Medical Device and Diagnostic Industry, acknowledged the great innovative power and particularly user-friendly operation of Bayer's CONTOUR USB meter.
Symphogen A/S today announced that it has initiated a Phase 1/2 human clinical trial in the US to evaluate the safety, tolerability and efficacy of its drug candidate Sym004 for the treatment of advanced solid tumors. Sym004 is composed of two anti-epidermal growth factor receptor monoclonal antibodies targeting different nonoverlapping EGFR epitopes.
Aridhia, the cloud-based data analysis platform provider, has agreed a new ten-year deal with Great Ormond Street Hospital NHS Foundation Trust which will see it deliver the research and innovation component of the Trust's multi-year digital transformation program.
› Verified 9 days ago
| Entity Name | Mountain View Emergency Physicians Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1619923653 PECOS PAC ID: 5092606376 Enrollment ID: O20040324000887 |
News Archive
Owlstone Medical, the global leader in Breath Biopsy® for applications in early disease detection and precision medicine, today announced the appointment of Mark Capone, former President and CEO of Myriad Genetics to its Board as an independent non-executive director.
Bruker Corporation today announced that it has acquired all of the shares of SkyScan N.V., a scientific instruments company located near Antwerp, Belgium. Financial details were not disclosed. For the remainder for 2012, the acquisition of SkyScan is expected to add approximately $13 million to Bruker's revenue and to be accretive to EPS by about $0.01.
Bayer's CONTOUR® USB meter, the first blood glucose monitor with unique plug & play diabetes management software, today received a silver Medical Design Excellence Award (MDEA). The MDEA recognizes excellence in medical product design and manufacturing. The independent judges for the prestigious award, sponsored by the specialist journal Medical Device and Diagnostic Industry, acknowledged the great innovative power and particularly user-friendly operation of Bayer's CONTOUR USB meter.
Symphogen A/S today announced that it has initiated a Phase 1/2 human clinical trial in the US to evaluate the safety, tolerability and efficacy of its drug candidate Sym004 for the treatment of advanced solid tumors. Sym004 is composed of two anti-epidermal growth factor receptor monoclonal antibodies targeting different nonoverlapping EGFR epitopes.
Aridhia, the cloud-based data analysis platform provider, has agreed a new ten-year deal with Great Ormond Street Hospital NHS Foundation Trust which will see it deliver the research and innovation component of the Trust's multi-year digital transformation program.
› Verified 9 days ago
| Entity Name | Mountain View Urgent Care Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1023306784 PECOS PAC ID: 7214107861 Enrollment ID: O20110908002279 |
News Archive
Owlstone Medical, the global leader in Breath Biopsy® for applications in early disease detection and precision medicine, today announced the appointment of Mark Capone, former President and CEO of Myriad Genetics to its Board as an independent non-executive director.
Bruker Corporation today announced that it has acquired all of the shares of SkyScan N.V., a scientific instruments company located near Antwerp, Belgium. Financial details were not disclosed. For the remainder for 2012, the acquisition of SkyScan is expected to add approximately $13 million to Bruker's revenue and to be accretive to EPS by about $0.01.
Bayer's CONTOUR® USB meter, the first blood glucose monitor with unique plug & play diabetes management software, today received a silver Medical Design Excellence Award (MDEA). The MDEA recognizes excellence in medical product design and manufacturing. The independent judges for the prestigious award, sponsored by the specialist journal Medical Device and Diagnostic Industry, acknowledged the great innovative power and particularly user-friendly operation of Bayer's CONTOUR USB meter.
Symphogen A/S today announced that it has initiated a Phase 1/2 human clinical trial in the US to evaluate the safety, tolerability and efficacy of its drug candidate Sym004 for the treatment of advanced solid tumors. Sym004 is composed of two anti-epidermal growth factor receptor monoclonal antibodies targeting different nonoverlapping EGFR epitopes.
Aridhia, the cloud-based data analysis platform provider, has agreed a new ten-year deal with Great Ormond Street Hospital NHS Foundation Trust which will see it deliver the research and innovation component of the Trust's multi-year digital transformation program.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Pablo R Razo, MD Po Box 4419, Woodland Hills, CA 91365-4419 Ph: (818) 340-9988 | Pablo R Razo, MD 999 San Bernardino Rd, Upland, CA 91786-4920 Ph: (909) 985-2811 |
News Archive
Owlstone Medical, the global leader in Breath Biopsy® for applications in early disease detection and precision medicine, today announced the appointment of Mark Capone, former President and CEO of Myriad Genetics to its Board as an independent non-executive director.
Bruker Corporation today announced that it has acquired all of the shares of SkyScan N.V., a scientific instruments company located near Antwerp, Belgium. Financial details were not disclosed. For the remainder for 2012, the acquisition of SkyScan is expected to add approximately $13 million to Bruker's revenue and to be accretive to EPS by about $0.01.
Bayer's CONTOUR® USB meter, the first blood glucose monitor with unique plug & play diabetes management software, today received a silver Medical Design Excellence Award (MDEA). The MDEA recognizes excellence in medical product design and manufacturing. The independent judges for the prestigious award, sponsored by the specialist journal Medical Device and Diagnostic Industry, acknowledged the great innovative power and particularly user-friendly operation of Bayer's CONTOUR USB meter.
Symphogen A/S today announced that it has initiated a Phase 1/2 human clinical trial in the US to evaluate the safety, tolerability and efficacy of its drug candidate Sym004 for the treatment of advanced solid tumors. Sym004 is composed of two anti-epidermal growth factor receptor monoclonal antibodies targeting different nonoverlapping EGFR epitopes.
Aridhia, the cloud-based data analysis platform provider, has agreed a new ten-year deal with Great Ormond Street Hospital NHS Foundation Trust which will see it deliver the research and innovation component of the Trust's multi-year digital transformation program.
› Verified 9 days ago
Kevin J Parkes, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 999 San Bernardino Rd, Upland, CA 91786 Phone: 909-985-2811 Fax: 818-587-2493 | |
Dr. Anthony Cabrera, DO Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 999 San Bernardino Rd, Upland, CA 91786 Phone: 909-985-2811 | |
Dwight W Guan, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 999 San Bernardino Rd, Upland, CA 91786 Phone: 909-985-2811 Fax: 818-587-2493 | |
Heather A Crane, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 999 San Bernardino Rd, Upland, CA 91786 Phone: 909-985-2811 Fax: 818-587-2493 | |
Allan D Bock, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 999 San Bernardino Rd, Upland, CA 91786 Phone: 909-985-2811 Fax: 818-587-2493 | |
Dr. Liezl Avila, D.O. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 999 San Bernardino Rd, Upland, CA 91786 Phone: 909-985-2811 | |
Dennis Trigueros, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 999 San Bernardino Rd, Upland, CA 91786 Phone: 909-985-2811 |